NYSE : CTEV
Claritev Corporation — Key statistics
Healthcare · Health Information Services · United States
Last price 24 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 406.74M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 405.47M |
| Enterprise Value | 5.08B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 16.95M |
| Shares Outstanding | 16.95M |
| Shares Change (YoY) | +2.50% |
| Shares Change (QoQ) | +1.63% |
| Owned by Insiders (%) | 8.46% |
| Owned by Institutions (%) | 30.67% |
| Float | 6.83M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 3.63 |
| PS Ratio | 0.41 |
| Forward PS | 0.39 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 3.07 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 5.11 |
| EV / EBITDA | 9.43 |
| EV / EBIT | 54.13 |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.00 |
| Quick Ratio | 0.69 |
| Debt / Equity | n/a |
| Debt / EBITDA | 8.63 |
| Debt / FCF | n/a |
| Interest Coverage | 0.23 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 1.19% |
| Return on Invested Capital (ROIC) | 2.05% |
| Return on Capital Employed (ROCE) | 2.08% |
| Weighted Average Cost of Capital (WACC) | 7.00% |
| Revenue Per Employee | $331,556 |
| Profits Per Employee | -$94,370 |
| Employee Count | 3,000 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -86.54M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -63.13% |
| 50-Day Moving Average | 28.78 |
| 200-Day Moving Average | 25.64 |
| Relative Strength Index (RSI) | 46.72 |
| Average Volume (20 Days) | 208,747 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 917,341 |
| Short Previous Month | 941,196 |
| Short % of Shares Out | 5.41% |
| Short % of Float | 13.42% |
| Short Ratio (days to cover) | 5.02 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 994.67M |
| Gross Profit | 725.77M |
| Operating Income | 93.99M |
| Pretax Income | -369.65M |
| Net Income | -283.11M |
| EBITDA | 539.46M |
| EBIT | 93.99M |
| Loss Per Share | -$16.99 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 14.37M |
| Total Debt | 4.69B |
| Net Cash | -4.68B |
| Net Cash Per Share | -$276.11 |
| Equity (Book Value) | -287.84M |
| Book Value Per Share | -17.39 |
| Working Capital | -1.09M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 133.04M |
| Capital Expenditures | -150.96M |
| Depreciation & Amortization | 445.47M |
| Net Borrowing | -24.69M |
| Free Cash Flow | -17.92M |
| FCF Per Share | -$1.06 |
Margins
| Measure | Value |
|---|
| Gross Margin | 72.97% |
| Operating Margin | 9.45% |
| Pretax Margin | -37.16% |
| Profit Margin | -28.46% |
| EBITDA Margin | 54.24% |
| EBIT Margin | 9.45% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.50% |
| Shareholder Yield | -2.50% |
| Earnings Yield | -70.99% |
| FCF Yield | -4.39% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $46.00 |
| Price Target Difference | 92.27% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 4.89% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 23, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.4 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |